DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,767 filers reported holding DANAHER CORPORATION in Q4 2020. The put-call ratio across all filers is 0.97 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $30,467,011 | +0.3% | 122,801 | -3.0% | 1.18% | +5.9% |
| Q2 2023 | $30,389,520 | +95569.8% | 126,623 | +0.5% | 1.11% | -8.8% |
| Q1 2023 | $31,765 | -5.3% | 126,030 | -0.3% | 1.22% | -7.5% |
| Q4 2022 | $33,541 | -99.9% | 126,371 | -0.7% | 1.32% | -6.3% |
| Q3 2022 | $32,867,000 | +3.8% | 127,247 | +1.8% | 1.40% | +7.6% |
| Q2 2022 | $31,676,000 | -1.4% | 124,946 | +14.1% | 1.30% | -27.0% |
| Q1 2022 | $32,130,000 | -10.5% | 109,533 | +0.4% | 1.79% | -5.2% |
| Q4 2021 | $35,889,000 | +9.6% | 109,082 | +1.4% | 1.89% | -8.8% |
| Q3 2021 | $32,754,000 | +12.7% | 107,585 | -0.6% | 2.07% | +12.0% |
| Q2 2021 | $29,059,000 | +19.5% | 108,285 | +0.2% | 1.85% | +12.4% |
| Q1 2021 | $24,313,000 | -12.5% | 108,020 | -13.6% | 1.64% | -18.4% |
| Q4 2020 | $27,772,000 | +3.3% | 125,020 | +0.1% | 2.01% | -9.7% |
| Q3 2020 | $26,889,000 | +22.7% | 124,872 | +0.8% | 2.23% | +15.3% |
| Q2 2020 | $21,910,000 | +29.7% | 123,900 | +1.5% | 1.94% | +7.6% |
| Q1 2020 | $16,898,000 | -10.1% | 122,086 | -0.3% | 1.80% | +12.4% |
| Q4 2019 | $18,800,000 | +5.1% | 122,488 | -1.1% | 1.60% | -2.0% |
| Q3 2019 | $17,890,000 | +1.0% | 123,865 | -0.1% | 1.63% | -1.4% |
| Q2 2019 | $17,711,000 | +7.9% | 123,929 | -0.3% | 1.66% | +3.6% |
| Q1 2019 | $16,410,000 | +29.5% | 124,293 | +1.2% | 1.60% | +13.3% |
| Q4 2018 | $12,671,000 | -4.9% | 122,871 | +0.2% | 1.41% | +3.6% |
| Q3 2018 | $13,328,000 | +10.1% | 122,654 | -0.0% | 1.36% | +2.0% |
| Q2 2018 | $12,107,000 | -0.1% | 122,689 | -0.8% | 1.33% | -1.3% |
| Q1 2018 | $12,115,000 | +1.5% | 123,733 | -3.8% | 1.35% | +2.8% |
| Q4 2017 | $11,935,000 | -13.0% | 128,576 | -19.6% | 1.31% | -18.3% |
| Q3 2017 | $13,723,000 | +2.8% | 159,978 | +1.2% | 1.61% | -0.5% |
| Q2 2017 | $13,345,000 | +1.1% | 158,129 | +2.5% | 1.62% | -3.3% |
| Q1 2017 | $13,200,000 | +10.5% | 154,330 | +0.6% | 1.67% | +6.6% |
| Q4 2016 | $11,944,000 | +48.2% | 153,444 | +49.2% | 1.57% | +43.1% |
| Q3 2016 | $8,062,000 | -9.8% | 102,843 | +16.2% | 1.10% | -7.7% |
| Q2 2016 | $8,939,000 | +7.3% | 88,507 | +0.8% | 1.19% | 0.0% |
| Q1 2016 | $8,331,000 | +4.4% | 87,830 | +2.2% | 1.19% | +6.8% |
| Q4 2015 | $7,983,000 | +10.3% | 85,956 | +1.2% | 1.11% | +0.6% |
| Q3 2015 | $7,239,000 | +5.6% | 84,951 | +6.1% | 1.10% | +13.4% |
| Q2 2015 | $6,853,000 | – | 80,069 | – | 0.97% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RobecoSam USA, Inc. | 74,961 | $7,572,000 | 9.43% |
| Corvid Peak Capital Management, LLC | 250,000 | $25,250,000 | 8.54% |
| CORTLAND ASSOCIATES INC/MO | 310,508 | $31,361,000 | 6.88% |
| Southpoint Capital Advisors LP | 1,250,000 | $126,250,000 | 6.75% |
| GREEN VALLEY INVESTORS LLC | 2,168,594 | $219,027,000 | 6.70% |
| DAVIS-REA LTD. | 75,080 | $7,595,000 | 5.39% |
| CADINHA & CO LLC | 247,143 | $24,961,000 | 5.35% |
| Espalier Global Management LLC | 47,100 | $4,757,000 | 5.25% |
| Spears Abacus Advisors LLC | 398,334 | $40,232,000 | 5.10% |
| GCA INVESTMENT MANAGEMENT, LLC | 158,064 | $15,964,000 | 5.01% |